| dc.contributor | Toral Garcés, Raúl | |
| dc.contributor | Flandoli, Franco | |
| dc.contributor.author | Ferrante, Patrizia | |
| dc.date | 2020 | |
| dc.date.accessioned | 2022-01-26T08:37:48Z | |
| dc.date.issued | 2020-12-11 | |
| dc.identifier.uri | http://hdl.handle.net/11201/156964 | |
| dc.description.abstract | [eng] The reprogramming of energy metabolism represents an important hallmark of cancer. The main cause of this alteration is represented by the presence of hypoxic areas. The decreased availability of oxygen activates the Hypoxia Inducible Factor (HIF) pathway which regulates the switch from an aerobic to an anaerobic metabolism, as well as an increased uptake of glucose. The aim of this thesis is multiple. In the first part we study and we numerically simulate a mathematical model consisting of four ordinary differential equations (ODEs): one for cancer cells with HIF inactivated, one for cancer cells with HIF activated and two for the metabolites cancer cells can consume in order to produce ATP. We model the dynamics of the transition between the two different behaviors, of cancer growth under normoxic and hypoxic conditions and of cancer progression in a hostile environment; furthermore we compare the behaviour of cancer cells in highlanders and lowlanders. In the second part we introduce a simple mathematical model to analyse the link between angiogenesis and the Warburg effect in cancer cells. We show that the the increased expression of glucose receptor is an important factor in the transition from initiation to cancer progression . We also show that the genetic polymorphism considered in highlanders does not provide useful information on cancer growth in the long term behaviour. The second model, despite only introduced, will let us formulate new questions concerning the role of the angiogenesis in cancer progression and fascinating links among different aspect of cancer metabolism. | ca |
| dc.format | application/pdf | |
| dc.language.iso | eng | ca |
| dc.publisher | Universitat de les Illes Balears | |
| dc.rights | all rights reserved | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | 616 - Patologia. Medicina clínica. Oncologia | ca |
| dc.subject.other | Cancer progression | ca |
| dc.subject.other | HIF pathway | ca |
| dc.subject.other | angiogenesis | ca |
| dc.title | Hypoxic response in cancer progression: modeling HIF activation | ca |
| dc.type | info:eu-repo/semantics/masterThesis | ca |
| dc.type | info:eu-repo/semantics/publishedVersion | |
| dc.date.updated | 2021-06-30T11:13:27Z | |
| dc.date.embargoEndDate | info:eu-repo/date/embargoEnd/2050-01-01 | |
| dc.embargo | 2050-01-01 | |
| dc.rights.accessRights | info:eu-repo/semantics/embargoedAccess |